Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.

Bibliographic Details
Title: Discovery, Optimization, and Preclinical Pharmacology of EP652, a METTL3 Inhibitor with Efficacy in Liquid and Solid Tumor Models.
Authors: Dutheuil, Guillaume, Oukoloff, Killian, Korac, Julien, Lenoir, François, El Bousmaqui, Mohamed, Probst, Nicolas, Lapin, Alexey, Nakhabina, Galina, Sorlet, Catherine, Parmentier, Nicolas, Karila, Delphine, Ghavtadze, Nugzar, Casault, Paméla, Claridge, Stephen, Sapmaz, Selma, Slater, Martin J., Fraser, Graeme L.
Source: Journal of Medicinal Chemistry; 2/13/2025, Vol. 68 Issue 3, p2981-3003, 23p
Database: Supplemental Index
More Details
ISSN:00222623
DOI:10.1021/acs.jmedchem.4c02225
Published in:Journal of Medicinal Chemistry
Language:English